Activating mutations in c-KIT and PDGFRalpha are exclusively found in gastrointestinal stromal tumors and not in other tumors overexpressing these imatinib mesylate target genes.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples